Alta Advisers Ltd Boosts Stock Holdings in McKesson Co. (NYSE:MCK)
by Renee Jackson · The Cerbat GemAlta Advisers Ltd lifted its holdings in McKesson Co. (NYSE:MCK – Free Report) by 5.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 422 shares of the company’s stock after acquiring an additional 22 shares during the quarter. Alta Advisers Ltd’s holdings in McKesson were worth $241,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of MCK. Te Ahumairangi Investment Management Ltd boosted its position in McKesson by 19.2% during the 3rd quarter. Te Ahumairangi Investment Management Ltd now owns 11,729 shares of the company’s stock valued at $5,766,000 after acquiring an additional 1,890 shares in the last quarter. World Investment Advisors LLC bought a new stake in McKesson during the third quarter valued at about $2,229,000. Wilmington Savings Fund Society FSB raised its holdings in McKesson by 817.1% in the third quarter. Wilmington Savings Fund Society FSB now owns 5,622 shares of the company’s stock worth $2,780,000 after purchasing an additional 5,009 shares in the last quarter. Tidal Investments LLC lifted its position in shares of McKesson by 453.8% during the third quarter. Tidal Investments LLC now owns 52,992 shares of the company’s stock valued at $26,200,000 after buying an additional 43,424 shares during the last quarter. Finally, Castellan Group boosted its holdings in shares of McKesson by 4.0% in the 3rd quarter. Castellan Group now owns 10,200 shares of the company’s stock valued at $5,043,000 after buying an additional 391 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several research analysts recently commented on the stock. Cfra Research lowered shares of McKesson from a “moderate buy” rating to a “hold” rating in a research note on Friday, April 4th. Evercore ISI upped their price target on McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a research report on Thursday, February 6th. Wells Fargo & Company raised their price objective on McKesson from $641.00 to $691.00 and gave the stock an “equal weight” rating in a research report on Friday, March 14th. Morgan Stanley upped their target price on McKesson from $642.00 to $745.00 and gave the company an “overweight” rating in a research report on Wednesday, April 2nd. Finally, Citigroup lowered their price target on McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Three analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $668.50.
Read Our Latest Analysis on MCK
Insider Transactions at McKesson
In other news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares of the company’s stock, valued at $36,276,465.36. This represents a 12.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Leann B. Smith sold 188 shares of McKesson stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the transaction, the executive vice president now owns 1,051 shares of the company’s stock, valued at approximately $640,679.09. This represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 18,110 shares of company stock valued at $10,855,706 in the last 90 days. 0.11% of the stock is currently owned by company insiders.
McKesson Price Performance
NYSE:MCK opened at $695.61 on Wednesday. The company’s fifty day moving average price is $655.50 and its 200-day moving average price is $603.03. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $728.32. The firm has a market capitalization of $87.18 billion, a P/E ratio of 31.85, a PEG ratio of 1.29 and a beta of 0.49.
McKesson (NYSE:MCK – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. Equities analysts anticipate that McKesson Co. will post 32.77 EPS for the current fiscal year.
McKesson Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd were given a $0.71 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $2.84 annualized dividend and a yield of 0.41%. McKesson’s dividend payout ratio is presently 13.00%.
McKesson Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Further Reading
- Five stocks we like better than McKesson
- Stock Analyst Ratings and Canadian Analyst Ratings
- How to Invest in Micro-Cap Stocks Like a Pro
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Take-Two Interactive: A Defensive Play Set to Explode
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).